Taisho Pharmaceutical Holdings Valuation
| TAIPYDelisted Stock | USD 14.00 0.00 0.00% |
At this time, the company appears to be overvalued. Taisho Pharmaceutical has a current Real Value of $11.48 per share. The regular price of the company is $14.0. Our model measures the value of Taisho Pharmaceutical from inspecting the company fundamentals such as Operating Margin of 0.09 %, return on equity of 0.0345, and Shares Outstanding of 327.94 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Taisho Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Taisho Pharmaceutical is based on 3 months time horizon. Increasing Taisho Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Taisho Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Taisho Pink Sheet. However, Taisho Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.0 | Real 11.48 | Hype 14.0 | Naive 14.95 |
The intrinsic value of Taisho Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Taisho Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Taisho Pharmaceutical Holdings helps investors to forecast how Taisho pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Taisho Pharmaceutical more accurately as focusing exclusively on Taisho Pharmaceutical's fundamentals will not take into account other important factors: Taisho Pharmaceutical Total Value Analysis
Taisho Pharmaceutical Holdings is at this time projected to have takeover price of 1.27 B with market capitalization of 3.35 B, debt of 0, and cash on hands of 276.54 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Taisho Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.27 B | 3.35 B | 0 | 276.54 B |
Taisho Pharmaceutical Investor Information
The company has price-to-book ratio of 0.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Taisho Pharmaceutical last dividend was issued on the 29th of September 2022. Taisho Pharmaceutical Holdings is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Taisho Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Taisho Pharmaceutical has an asset utilization ratio of 30.2 percent. This suggests that the Company is making $0.3 for each dollar of assets. An increasing asset utilization means that Taisho Pharmaceutical Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Taisho Pharmaceutical Profitability Analysis
The company reported the revenue of 268.2 B. Net Income was 13.12 B with profit before overhead, payroll, taxes, and interest of 163.83 B.About Taisho Pharmaceutical Valuation
Our relative valuation model uses a comparative analysis of Taisho Pharmaceutical. We calculate exposure to Taisho Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Taisho Pharmaceutical's related companies.Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter drugs and prescription pharmaceutical products in Japan and internationally. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan. Taisho Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9134 people.
8 Steps to conduct Taisho Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Taisho Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Taisho Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Taisho Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Taisho Pharmaceutical's revenue streams: Identify Taisho Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Taisho Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Taisho Pharmaceutical's growth potential: Evaluate Taisho Pharmaceutical's management, business model, and growth potential.
- Determine Taisho Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Taisho Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Taisho Pharmaceutical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 326.2 M | |
| Quarterly Earnings Growth Y O Y | 0.652 | |
| Forward Price Earnings | 36.63 | |
| Retained Earnings | 703 B |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |